FDA Drug Safety Communication: Bisphosphonates and Esophageal Cancer
The U.S. Food and Drug Administration (FDA) is continuing to review data from published studies to evaluate whether use of oral bisphosphonate drugs is associated with an increased risk of cancer of the esophagus (esophageal cancer).
Multiple Sclerosis Quickly Affects Bone Health
Patients with multiple sclerosis (MS) are at risk for low bone density and osteoporosis. New information shows that promptly addressing bone health in these patients is necessary.
Yet Another Reason to Lose Weight
Being overweight or obese carries a number of health risks. Now there's one more health benefit for losing weight.
Boning Up for Menopause Helps Colons
Women trying to treat their menopause symptoms with hormone replacement therapy drugs have heard for years of the potentially terrible side effects they can cause. However, some medications not only treat one ailment, but might even prevent another.
New Findings on Hormone Replacement Therapy
You may remember some years ago when a large women's study was stopped because one of the therapies being tested was shown to actually increase the risk of breast cancer, heart attacks and strokes.
Common Osteoporosis Drugs Linked to Increased Cancer Risk
Oral bisphosphonates, a treatment for bone disease, may double the risk of developing esophageal cancer (cancer of the gullet), according to a new study from the University of Oxford.